NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseNov 13, 2026 3:59:58 PM EST
41.64USD+2.435%(+0.99)11,714,402
Pre-marketNov 13, 2026 9:29:30 AM EST
40.87USD+0.541%(+0.22)
After-hoursNov 13, 2026 4:56:30 PM EST
41.47USD-0.404%(-0.17)
NVO News
Lilly’s Zepbound shows promise in teen obesity trial · 
Seeking Alpha
Novo Nordisk reports additional CagriSema weight-loss findings · Seeking Alpha
LifeMD: 3 Key Takeaways for Long-Term Investors · 
The Motley Fool+1 source
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027? · The Motley Fool+1 source
Novo Nordisk Receives EU Approval for Hemophilia A Drug Frehemgo · 
Securities.io